Clinical Data Visualization • March 2026
Urolithin A: Revitalizing Cellular Health Through Mitophagy
As humans age, cellular energy centers—mitochondria—decline in function, leading to age-related physiological degradation. Recent clinical studies highlight Urolithin A (UA), a postbiotic gut microbiome metabolite, as a potent activator of mitophagy.
Urolithin A: Revitalizing Cellular Health Through Mitophagy
Clinical Data Visualization • Mt. Angel Vitamins • March 2026
The Mitophagy Activation Pathway
From dietary precursors to cellular renewal—how Urolithin A activates the body's mitochondrial recycling system.
The Bioavailability Gap
Only ~35% of the population naturally produces Urolithin A from dietary precursors. The remaining 65% lack the specific gut bacteria required for conversion, making direct supplementation the only reliable path to therapeutic levels.
Muscle Endurance Over Time
Percentage increase in skeletal muscle endurance over a 4-month supplementation period (1000 mg UA daily vs. placebo).
Inflammatory Biomarker Reduction
UA supplementation significantly reduced systemic markers of inflammation and mitochondrial stress, including C-reactive protein and acylcarnitines.
ATP Production vs. Mitochondrial Density
Each point represents an individual participant. UA supplementation clusters toward higher mitochondrial density and ATP output.
Want the full clinical analysis?
Dive into the complete white paper covering biosynthesis pathways, immunometabolism, neuroprotection, pharmacokinetics, and safety data.
Read the Full White Paper →Data visualizations are based on published clinical trial results. For educational purposes. This content does not constitute medical advice. Mt. Angel Vitamins does not manufacture or sell urolithin A supplements.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.